PainReform Ltd. Files 6-K for Registration Statement Updates
Ticker: PRFX · Form: 6-K · Filed: Oct 16, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Oct 16, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1.35 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, procedural
TL;DR
PainReform files 6-K, just procedural updates to existing stock registration, no new news.
AI Summary
PainReform Ltd. filed a Form 6-K on October 16, 2024, to incorporate by reference this report into its existing Registration Statements on Form S-8 and Form F-3. This filing does not contain new financial information but serves to update ongoing registration statements for securities.
Why It Matters
This filing is procedural, updating existing registration statements. It indicates ongoing compliance and potential future share issuances or offerings without disclosing new operational or financial developments.
Risk Assessment
Risk Level: low — The filing is a routine procedural update and does not introduce new material risks or financial information.
Key Players & Entities
- PainReform Ltd. (company) — Registrant
- 001-39481 (company) — SEC File Number
- 333-257968 (company) — Form S-8 Registration Number
- 333-265902 (company) — Form S-8 Registration Number
- 333-254982 (company) — Form F-3 Registration Number
- 333-276485 (company) — Form F-3 Registration Number
- 333-277954 (company) — Form F-3 Registration Number
- 333-282264 (company) — Form F-3 Registration Number
FAQ
What is the purpose of this Form 6-K filing by PainReform Ltd.?
The Form 6-K is filed to incorporate by reference into the registrant's existing Registration Statements on Form S-8 and Form F-3.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on October 16, 2024.
Which specific registration statements are being updated by this filing?
This filing is incorporated into Registration Statements on Form S-8 (No. 333-257968 and 333-265902) and Form F-3 (No. 333-254982, 333-276485, 333-277954, and 333-282264).
Does this filing contain new financial results for PainReform Ltd.?
No, this filing is for incorporation by reference into existing registration statements and does not appear to contain new financial results or operational updates.
What is the principal executive office address for PainReform Ltd.?
The principal executive offices are located at 65 Yigal Alon St., Tel Aviv 6744316, Israel.
Filing Stats: 797 words · 3 min read · ~3 pages · Grade level 11.7 · Accepted 2024-10-16 16:35:07
Key Financial Figures
- $1.35 million — ng an aggregate offering price of up to $1.35 million (the "Shares"). The offer and sale of
Filing Documents
- zk2432144.htm (6-K) — 16KB
- exhibit_5-1.htm (EX-5.1) — 16KB
- exhibit_10-1.htm (EX-10.1) — 224KB
- image00001.jpg (GRAPHIC) — 7KB
- 0001178913-24-003327.txt ( ) — 266KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 16, 2024 By: /s/ Ehud Geller Ehud Geller Interim Chief Executive Officer